Nes-Ziona, Israel, April 16, 2024 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy […]
GEORGE TOWN, Grand Cayman, April 16, 2024 (GLOBE NEWSWIRE) — StoneCo Ltd. (Nasdaq: STNE, B3: STOC31) (“Stone”) announces that it […]
— Amendment replaces saline injections with sham injections in the control group — MELVILLE, N.Y., April 16, 2024 (GLOBE NEWSWIRE) […]
SHANGHAI, China and NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) — TH International Limited (“Tims China” (Nasdaq: THCH)), the exclusive […]
The counter unmanned aircraft system (C-UAS) market is estimated to reach over $15 billion by 2032 Tel Aviv, Israel, April […]
CANTON, Mass., April 16, 2024 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on […]
Hong Kong, April 16, 2024 (GLOBE NEWSWIRE) — Top Wealth Group Holding Limited (the “Company” or “Top Wealth”), a Hong […]
MARLBOROUGH, Mass., April 16, 2024 (GLOBE NEWSWIRE) — Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary […]
SARASOTA, Fla., April 16, 2024 (GLOBE NEWSWIRE) — Trump Media & Technology Group Corp. (NASDAQ:DJT) (“TMTG” or the “Company”), operator […]
MIAMI BEACH, Fla., April 16, 2024 (GLOBE NEWSWIRE) — SAB Biotherapeutics, Inc. (Nasdaq: SABS), (“SAB” or the “Company”), a clinical-stage biopharmaceutical […]
